Trial of PreoperAtive Radiation (TOPAz): a Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy with Immediate Autologous Breast Reconstruction with Integrated Nanomechanical Biomarker Evaluation
Phase 3
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Radiation: Group 1 (preoperative radiation hypofractionated)Other: Group 2 (preoperative radiation conventionally fractionated)
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 126
- Registration Number
- NCT05774678
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
Phase 1
Recruiting
- Conditions
- LymphomasB-cell Lymphomas
- Interventions
- Drug: JV-213Procedure: Leukapheresis
- First Posted Date
- 2023-03-17
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT05773040
- Locations
- 🇺🇸
The University of Texas M D Anderson Cancer Center, Houston, Texas, United States
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Phase 2
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Group 1Behavioral: Group 2Behavioral: Group 3
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 225
- Registration Number
- NCT05766891
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer
Not Applicable
Recruiting
- Conditions
- Cancer
- Interventions
- Behavioral: Individual InterviewBehavioral: Meditation Exercise
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT05763797
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study
Not Applicable
Recruiting
- Conditions
- Smoking
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT05763771
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT05761951
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Harmony & Health: Feasibility of a Movement Intervention to Improve Psychosocial Wellbeing in Black Adults in Northeast Texas
Not Applicable
Recruiting
- Conditions
- Psychological
- Interventions
- Behavioral: Harmony & HealthBehavioral: Health Education
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT05761964
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
3D Printed Breast Models in the Surgical Management of Breast Cancer
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT05755984
Vapocoolant Analgesia for Breast Lymphoscintigraphy
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Other: num Vapocoolant
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05744557
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning
Not Applicable
Active, not recruiting
- Conditions
- Liver Cancer
- Interventions
- Device: TriSalus™ TriNav™Infusion SystemDiagnostic Test: AngiogramProcedure: Y90-radioembolization procedure
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT05743842
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath